We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle (ALB) Dips More Than Broader Markets: What You Should Know
Read MoreHide Full Article
Albemarle (ALB - Free Report) closed the most recent trading day at $168.21, moving -0.43% from the previous trading session. This change lagged the S&P 500's daily loss of 0.23%. Meanwhile, the Dow lost 0.31%, and the Nasdaq, a tech-heavy index, lost 0.09%.
Coming into today, shares of the specialty chemicals company had lost 11.43% in the past month. In that same time, the Basic Materials sector lost 2.9%, while the S&P 500 lost 1.43%.
Albemarle will be looking to display strength as it nears its next earnings release. The company is expected to report EPS of $4.14, down 44.8% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.41 billion, up 15.06% from the year-ago period.
ALB's full-year Zacks Consensus Estimates are calling for earnings of $26.09 per share and revenue of $10.45 billion. These results would represent year-over-year changes of +18.81% and +42.72%, respectively.
It is also important to note the recent changes to analyst estimates for Albemarle. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.83% higher within the past month. Albemarle is currently a Zacks Rank #3 (Hold).
Valuation is also important, so investors should note that Albemarle has a Forward P/E ratio of 6.47 right now. This represents a discount compared to its industry's average Forward P/E of 14.91.
Meanwhile, ALB's PEG ratio is currently 0.55. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. ALB's industry had an average PEG ratio of 1.89 as of yesterday's close.
The Chemical - Diversified industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 196, which puts it in the bottom 23% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Albemarle (ALB) Dips More Than Broader Markets: What You Should Know
Albemarle (ALB - Free Report) closed the most recent trading day at $168.21, moving -0.43% from the previous trading session. This change lagged the S&P 500's daily loss of 0.23%. Meanwhile, the Dow lost 0.31%, and the Nasdaq, a tech-heavy index, lost 0.09%.
Coming into today, shares of the specialty chemicals company had lost 11.43% in the past month. In that same time, the Basic Materials sector lost 2.9%, while the S&P 500 lost 1.43%.
Albemarle will be looking to display strength as it nears its next earnings release. The company is expected to report EPS of $4.14, down 44.8% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.41 billion, up 15.06% from the year-ago period.
ALB's full-year Zacks Consensus Estimates are calling for earnings of $26.09 per share and revenue of $10.45 billion. These results would represent year-over-year changes of +18.81% and +42.72%, respectively.
It is also important to note the recent changes to analyst estimates for Albemarle. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.83% higher within the past month. Albemarle is currently a Zacks Rank #3 (Hold).
Valuation is also important, so investors should note that Albemarle has a Forward P/E ratio of 6.47 right now. This represents a discount compared to its industry's average Forward P/E of 14.91.
Meanwhile, ALB's PEG ratio is currently 0.55. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. ALB's industry had an average PEG ratio of 1.89 as of yesterday's close.
The Chemical - Diversified industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 196, which puts it in the bottom 23% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.